vs
AMPCO PITTSBURGH CORP（AP）与Esperion Therapeutics, Inc.（ESPR）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是AMPCO PITTSBURGH CORP的1.6倍（$168.4M vs $104.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 11.5%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs -2.6%）
安普科匹兹堡公司是一家特种钢材制造商，总部位于宾夕法尼亚州匹兹堡市中心，1929年由多家此前已成立的小型钢铁企业合并组建而成。需要注意区分它和其他同样带有Ampco名称的企业，比如位于密尔沃基的铜基合金生产商、迈阿密的橱柜企业等。
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
AP vs ESPR — 直观对比
营收规模更大
ESPR
是对方的1.6倍
$104.4M
营收增速更快
ESPR
高出132.3%
11.5%
两年增速更快
ESPR
近两年复合增速
-2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $104.4M | $168.4M |
| 净利润 | $-57.7M | — |
| 毛利率 | — | — |
| 营业利润率 | -54.0% | 50.6% |
| 净利率 | -55.2% | — |
| 营收同比 | 11.5% | 143.7% |
| 净利润同比 | -1958.9% | — |
| 每股收益（稀释后） | $-2.87 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APESPR
| Q4 25 | $104.4M | $168.4M | ||
| Q3 25 | $103.7M | $87.3M | ||
| Q2 25 | $108.9M | $82.4M | ||
| Q1 25 | $99.2M | $65.0M | ||
| Q4 24 | $93.6M | $69.1M | ||
| Q3 24 | $92.1M | $51.6M | ||
| Q2 24 | $107.1M | $73.8M | ||
| Q1 24 | $110.0M | $137.7M |
净利润APESPR
| Q4 25 | $-57.7M | — | ||
| Q3 25 | $-2.2M | $-31.3M | ||
| Q2 25 | $-7.3M | $-12.7M | ||
| Q1 25 | $1.1M | $-40.5M | ||
| Q4 24 | $3.1M | — | ||
| Q3 24 | $-2.0M | $-29.5M | ||
| Q2 24 | $2.0M | $-61.9M | ||
| Q1 24 | $-2.7M | $61.0M |
营业利润率APESPR
| Q4 25 | -54.0% | 50.6% | ||
| Q3 25 | 1.1% | -11.4% | ||
| Q2 25 | -2.8% | 8.6% | ||
| Q1 25 | 3.9% | -34.0% | ||
| Q4 24 | 5.5% | -6.4% | ||
| Q3 24 | 2.0% | -31.0% | ||
| Q2 24 | 4.7% | 3.5% | ||
| Q1 24 | 0.1% | 52.5% |
净利率APESPR
| Q4 25 | -55.2% | — | ||
| Q3 25 | -2.1% | -35.9% | ||
| Q2 25 | -6.7% | -15.4% | ||
| Q1 25 | 1.2% | -62.2% | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | -2.1% | -57.2% | ||
| Q2 24 | 1.9% | -83.9% | ||
| Q1 24 | -2.5% | 44.3% |
每股收益（稀释后）APESPR
| Q4 25 | $-2.87 | $0.32 | ||
| Q3 25 | $-0.11 | $-0.16 | ||
| Q2 25 | $-0.36 | $-0.06 | ||
| Q1 25 | $0.06 | $-0.21 | ||
| Q4 24 | $0.16 | $-0.14 | ||
| Q3 24 | $-0.10 | $-0.15 | ||
| Q2 24 | $0.10 | $-0.33 | ||
| Q1 24 | $-0.14 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.7M | $167.9M |
| 总债务越低越好 | $117.9M | — |
| 股东权益账面价值 | $32.6M | $-302.0M |
| 总资产 | $495.4M | $465.9M |
| 负债/权益比越低杠杆越低 | 3.61× | — |
8季度趋势，按日历期对齐
现金及短期投资APESPR
| Q4 25 | $10.7M | $167.9M | ||
| Q3 25 | $15.0M | $92.4M | ||
| Q2 25 | $9.9M | $86.1M | ||
| Q1 25 | $7.1M | $114.6M | ||
| Q4 24 | $15.4M | $144.8M | ||
| Q3 24 | $11.8M | $144.7M | ||
| Q2 24 | $7.9M | $189.3M | ||
| Q1 24 | $10.8M | $226.6M |
总债务APESPR
| Q4 25 | $117.9M | — | ||
| Q3 25 | $119.0M | — | ||
| Q2 25 | $115.9M | — | ||
| Q1 25 | $115.0M | — | ||
| Q4 24 | $116.4M | — | ||
| Q3 24 | $116.0M | — | ||
| Q2 24 | $119.4M | — | ||
| Q1 24 | $116.2M | — |
股东权益APESPR
| Q4 25 | $32.6M | $-302.0M | ||
| Q3 25 | $60.1M | $-451.4M | ||
| Q2 25 | $62.7M | $-433.5M | ||
| Q1 25 | $64.6M | $-426.2M | ||
| Q4 24 | $58.9M | $-388.7M | ||
| Q3 24 | $61.3M | $-370.2M | ||
| Q2 24 | $58.0M | $-344.2M | ||
| Q1 24 | $56.3M | $-294.3M |
总资产APESPR
| Q4 25 | $495.4M | $465.9M | ||
| Q3 25 | $524.4M | $364.0M | ||
| Q2 25 | $537.2M | $347.1M | ||
| Q1 25 | $536.2M | $324.0M | ||
| Q4 24 | $530.9M | $343.8M | ||
| Q3 24 | $547.4M | $314.1M | ||
| Q2 24 | $560.8M | $352.3M | ||
| Q1 24 | $565.8M | $373.1M |
负债/权益比APESPR
| Q4 25 | 3.61× | — | ||
| Q3 25 | 1.98× | — | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 1.78× | — | ||
| Q4 24 | 1.98× | — | ||
| Q3 24 | 1.89× | — | ||
| Q2 24 | 2.06× | — | ||
| Q1 24 | 2.06× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.7M | $45.2M |
| 自由现金流经营现金流 - 资本支出 | $-64.0K | — |
| 自由现金流率自由现金流/营收 | -0.1% | — |
| 资本支出强度资本支出/营收 | 2.7% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.1M | — |
8季度趋势，按日历期对齐
经营现金流APESPR
| Q4 25 | $2.7M | $45.2M | ||
| Q3 25 | $6.3M | $-4.3M | ||
| Q2 25 | $-2.3M | $-31.4M | ||
| Q1 25 | $-5.3M | $-22.6M | ||
| Q4 24 | $7.5M | $-35.0M | ||
| Q3 24 | $11.4M | $-35.3M | ||
| Q2 24 | $-5.3M | $-7.2M | ||
| Q1 24 | $4.5M | $53.8M |
自由现金流APESPR
| Q4 25 | $-64.0K | — | ||
| Q3 25 | $3.3M | — | ||
| Q2 25 | $-3.8M | — | ||
| Q1 25 | $-7.5M | — | ||
| Q4 24 | $3.7M | — | ||
| Q3 24 | $8.4M | $-35.5M | ||
| Q2 24 | $-8.0M | $-7.3M | ||
| Q1 24 | $1.7M | $53.8M |
自由现金流率APESPR
| Q4 25 | -0.1% | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | -3.5% | — | ||
| Q1 25 | -7.5% | — | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 9.1% | -68.7% | ||
| Q2 24 | -7.5% | -9.9% | ||
| Q1 24 | 1.5% | 39.0% |
资本支出强度APESPR
| Q4 25 | 2.7% | 0.0% | ||
| Q3 25 | 2.9% | 0.0% | ||
| Q2 25 | 1.3% | 0.0% | ||
| Q1 25 | 2.2% | 0.0% | ||
| Q4 24 | 4.0% | 0.0% | ||
| Q3 24 | 3.2% | 0.3% | ||
| Q2 24 | 2.5% | 0.1% | ||
| Q1 24 | 2.6% | 0.1% |
现金转化率APESPR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -4.62× | — | ||
| Q4 24 | 2.40× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -2.64× | — | ||
| Q1 24 | — | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AP
| Forged And Cast Mill Rolls | $67.0M | 64% |
| Air Handling Systems | $14.3M | 14% |
| Heat Exchange Coils | $13.1M | 13% |
| Centrifugal Pumps | $10.3M | 10% |
| Forged Engineered Products | $4.0M | 4% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
